Company / Return on Assets (ROA)
Biogen Return on Assets (ROA) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
4.4%
FY2025
5-year range
4.3% / 12.4%
FY2021-FY2025
Trend
-24.6%
vs FY2024
Sector context
#39 of 213
Health Care
What the data says
Biogen's return on assets (roa) of 4.4% is higher than 82% of companies in the Health Care sector (FY2025). Return on Assets (ROA) has fluctuated over the past 10 years, ranging from 4.3% in FY2023 to 21.6% in FY2019.
Based on SEC 10-K filings.
4.4% in FY2025 with a 5-year CAGR of -11.9%. Top quartile in the Health Care sector.
Remained stable around 4.4% over the past 2 years.
Health Care sector context is included.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- -8.0pp
- 5-Year Change
- -11.9pp
- 10-Year Change
- -
Sector benchmark
+118.3% above sector average
Key checks
Key Insights
- In FY2025, return on assets (roa) decreased 24.6% year-over-year.
- Currently 28.4pp above the Health Care sector average.
- Peak return on assets (roa) was recorded in FY2019.
- Lowest return on assets (roa) in the period was in FY2023.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | 4.4% | -24.6% |
| FY2024 | 5.8% | +34.4% |
| FY2023 | 4.3% | -65.1% |
| FY2022 | 12.4% | +90.3% |
| FY2021 | 6.5% | -59.9% |
| FY2020 | 16.3% | -24.8% |
| FY2019 | 21.6% | +23.4% |
| FY2018 | 17.5% | +63.3% |
| FY2017 | 10.7% | -33.7% |
| FY2016 | 16.2% | -11.0% |
As of FY2025 · SEC 10-K · Updated Mar 3, 2026